CDC SEEKING CRADA PARTNER FOR REVERSE TRANSCRIPTASE ASSAY
This article was originally published in The Gray Sheet
Executive Summary
CDC SEEKING CRADA PARTNER FOR REVERSE TRANSCRIPTASE ASSAY, the Centers for Disease Control and Prevention announced in the Oct. 18 Federal Register. The assay "uses an in vitro transcribed heteropolyrneric RNA sequence for the RT enzyme template, and gene amplification with Southern blot hybridization as the detection system for the cDNA product of the reaction," the notice states.